First published 10/3/2026, 8:53:15 PM · Last updated 10/3/2026, 8:53:15 PM

Broad-Shouldered Survival Curves of a Human Melanoma Xenograft Implications for radiation therapy in the absence and presence of misonidazole

Journal article reporting on broad-shouldered survival curves of a human melanoma xenograft and discussing implications for radiation therapy with and without misonidazole. Publisher listed as MJS Publishing, Medical Journals Sweden AB; no study results or locations are provided in the supplied data.

Categories: science-and-space, public-health

Generated scores

Scores are based on the cited reporting and use a 1–10 scale. Read the methodology.

Confidence: 5/10How certain the assessment is based on the clarity and evidence in the cited reporting.
Geographic reach: 1/10How widely the event reaches, from a local area (1) to worldwide impact (10).
Global importance: 2/10The event's broader significance, from limited importance (1) to major global importance (10).
Impact magnitude: 2/10The scale or severity of the real-world impact, from minor (1) to extreme (10).
Positivity: 5/10How harmful or beneficial the event is, from strongly harmful (1) to strongly positive (10).
Urgency: 1/10How time-sensitive the event is, from low urgency (1) to immediate attention needed (10).

Why it matters

The article addresses radiation therapy considerations for a human melanoma xenograft involving the radiosensitizer misonidazole, which is relevant to medical research and oncology practice.

Sources

Broad-Shouldered Survival Curves of a Human Melanoma Xenograft Implications for radiation therapy in the absence and presence of misonidazoleMetadata provided by Crossref. Usage terms

Report an issue